跳轉至內容
Merck

Otitis media.

Pediatric clinics of North America (2013-03-14)
Michael E Pichichero
摘要

Acute otitis media (AOM) is diagnosed based on visualization of a full or bulging tympanic membrane with middle ear effusion. The distribution of bacteria causing AOM in North America under the influence of pneumococcal conjugate vaccination and antibiotic selection pressure has resulted in a predominance of β-lactamase-producing Haemophilus influenzae followed by penicillin-resistant Streptococcus pneumoniae. Although guidelines continue to endorse amoxicillin as the preferred treatment, amoxicillin/clavulanate in high dosage would be the preferred treatment based on the otopathogen mix currently. Antibiotic prophylaxis has fallen into disfavor as a preventative strategy for AOM recurrences.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
阿莫西林, 95.0-102.0% anhydrous basis
Supelco
阿莫西林 三水合物, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Cefpodoxime proxetil, United States Pharmacopeia (USP) Reference Standard
Supelco
阿莫西林 三水合物, VETRANAL®, analytical standard
Supelco
头孢呋辛, VETRANAL®, analytical standard
Cefpodoxime proxetil, European Pharmacopoeia (EP) Reference Standard
Cefpodoxime proxetil for peak identification, European Pharmacopoeia (EP) Reference Standard
Cefpodoxime proxetil for impurity H identification, European Pharmacopoeia (EP) Reference Standard